IP Library Granted Patent US 9,566,402
Granted Patent B2
US 9,566,402 · App. 14/822,404 · Granted Feb 14, 2017

Delivery Device and Method

Inventor: Per Gisle Djupesland (Oslo, NO)
Assignee: OptiNose AS
A61M15/0098A61M15/009A61M15/0021A61M15/0091A61M15/08A61M16/0493A61M16/0495A61M16/0434A61M2016/0021A61M2016/0027A61M2202/064A61M2202/30A61M2210/065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,566,402
App. No.
14/822,404
Granted
Feb 14, 2017
Kind
B2
Abstract

A delivery device for and method of delivering substance, in particular a vaccine, to a mucosal surface within the oral cavity of a subject, the device comprising: a mouthpiece unit to be gripped in the mouth of a subject, wherein the mouthpiece unit is configured such that, on exhalation or attempted exhalation by the subject, a pressure is developed in the oral cavity which is such as to close the oropharyngeal velum of the subject; and an oral outlet unit including at least one outlet from which substance is in use delivered to a mucosal surface within the oral cavity of the subject.

Claims (28)

1. A delivery device for delivering a substance into an oral cavity of a subject, the device comprising:

a mouthpiece unit configured such that exhalation or attempted exhalation by the subject into the mouthpiece unit closes the oropharyngeal velum of the subject;

an oral outlet unit including at least one substance outlet from which the substance is delivered into the oral cavity of the subject; and

a substance supply unit which is actuatable to deliver the substance from the at least one substance outlet.

2. The delivery device of claim 1 , further comprising a reflex-inducing fluid delivery unit for delivering a reflex-inducing fluid to the subject.

3. The delivery device of claim 2 , further comprising a trigger unit configured to actuate both the substance supply unit and the reflex-inducing fluid delivery unit.

4. The delivery device of claim 1 , further comprising a sucker element configured to fix the position of the at least one substance outlet relative to a hard palate of the subject.

5. The delivery device of claim 2 , wherein the reflex-inducing fluid is air.

6. The delivery device of claim 2 , wherein the reflex-inducing fluid is water.

7. The delivery device of claim 1 , wherein the substance is a medicament.

8. The delivery device of claim 1 , wherein the substance is a vaccine.

9. The delivery device of claim 1 , wherein the oral outlet unit is targeted to deliver the substance to the palatine tonsils of the subject.

10. The delivery device of claim 1 , wherein the oral outlet unit is targeted to deliver the substance to a mucosal surface within the oral cavity of the subject.

11. The delivery device of claim 1 , wherein the substance supply unit delivers a metered dose of the substance.

12. A delivery device for delivering a substance into the oral cavity of a subject, the device comprising:

a mouthpiece unit configured to be gripped in a mouth of the subject such that exhalation or attempted exhalation by the subject into the mouthpiece unit closes the oropharyngeal velum of the subject;

an oral outlet unit including at least one substance outlet from which the substance is delivered into the oral cavity of the subject;

an oral outlet unit positioner comprising a tongue depressor for depressing the tongue of the subject when the mouthpiece unit is gripped in the mouth of the subject.

13. The delivery device of claim 12 , wherein the substance is a medicament.

14. The delivery device of claim 12 , wherein the substance is a vaccine.

15. The delivery device of claim 12 , wherein the tongue depressor is movable relative to the mouthpiece unit.

16. The delivery device of claim 12 , wherein the oral outlet unit is targeted to deliver the substance to the palatine tonsils of the subject.

17. The delivery device of claim 12 , wherein the mouthpiece unit comprises a mouthpiece including a flow channel through which the subject exhales to develop an exhalation air flow through the delivery device.

18. The delivery device of claim 12 , further comprising a delivery unit comprising a substance supply unit which is actuatable to deliver the substance from the at least one substance outlet.

19. The delivery device of claim 18 , further comprising a trigger unit configured to actuate the substance supply unit.

20. The delivery device of claim 18 , wherein the substance supply unit contains multiple doses of the substance.

21. The delivery device of claim 18 , wherein the substance supply unit delivers a metered dose of the substance.

22. The delivery unit of claim 12 , wherein the substance is a powder.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 7, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069833/0470 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: DJUPESLAND, PER GISLE
To: OPTINOSE AS
Reel/Frame 042711/0206 →
Priority Claims (1)
GB 0311570.6 · May 20, 2003 · national
Continuity (3)
Continuation 13724560 · Dec 21, 2012
Continuation 10557559
Related Publication 20160184537A1 · Jun 30, 2016